Logo image of STRF

STRATEGY INC - MSTR 10 PERP (STRF) Stock Fundamental Analysis

NASDAQ:STRF - US5949728795

111.35 USD
+0.22 (+0.2%)
Last: 9/5/2025, 8:00:01 PM
Fundamental Rating

3

Overall STRF gets a fundamental rating of 3 out of 10. We evaluated STRF against 281 industry peers in the Software industry. There are concerns on the financial health of STRF while its profitability can be described as average. STRF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year STRF was profitable.
In the past year STRF has reported a negative cash flow from operations.
In the past 5 years STRF reported 4 times negative net income.
Of the past 5 years STRF 4 years had a positive operating cash flow.
STRF Yearly Net Income VS EBIT VS OCF VS FCFSTRF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B -15B -20B

1.2 Ratios

Looking at the Return On Assets, with a value of 7.31%, STRF is in the better half of the industry, outperforming 77.94% of the companies in the same industry.
The Return On Equity of STRF (9.40%) is better than 75.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.90%, STRF belongs to the top of the industry, outperforming 84.34% of the companies in the same industry.
Industry RankSector Rank
ROA 7.31%
ROE 9.4%
ROIC 9.9%
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STRF Yearly ROA, ROE, ROICSTRF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

STRF has a better Profit Margin (1023.69%) than 98.58% of its industry peers.
The Operating Margin of STRF (1747.64%) is better than 98.93% of its industry peers.
STRF has a Gross Margin (70.10%) which is in line with its industry peers.
STRF's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1747.64%
PM (TTM) 1023.69%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
STRF Yearly Profit, Operating, Gross MarginsSTRF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), STRF is destroying value.
The number of shares outstanding for STRF has been increased compared to 1 year ago.
The number of shares outstanding for STRF has been increased compared to 5 years ago.
Compared to 1 year ago, STRF has an improved debt to assets ratio.
STRF Yearly Shares OutstandingSTRF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
STRF Yearly Total Debt VS Total AssetsSTRF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

STRF has an Altman-Z score of 2.09. This is not the best score and indicates that STRF is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.09, STRF perfoms like the industry average, outperforming 49.82% of the companies in the same industry.
STRF has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
STRF has a Debt to Equity ratio (0.16) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 2.09
ROIC/WACC0.94
WACC10.5%
STRF Yearly LT Debt VS Equity VS FCFSTRF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B -20B

2.3 Liquidity

STRF has a Current Ratio of 0.68. This is a bad value and indicates that STRF is not financially healthy enough and could expect problems in meeting its short term obligations.
STRF has a Current ratio of 0.68. This is amonst the worse of the industry: STRF underperforms 85.41% of its industry peers.
STRF has a Quick Ratio of 0.68. This is a bad value and indicates that STRF is not financially healthy enough and could expect problems in meeting its short term obligations.
STRF's Quick ratio of 0.68 is on the low side compared to the rest of the industry. STRF is outperformed by 85.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
STRF Yearly Current Assets VS Current LiabilitesSTRF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

STRF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2065.44%, which is quite impressive.
The Revenue has decreased by -3.81% in the past year.
Measured over the past years, STRF shows a decrease in Revenue. The Revenue has been decreasing by -0.96% on average per year.
EPS 1Y (TTM)2065.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5779.44%
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%2.73%

3.2 Future

STRF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.49% yearly.
The Revenue is expected to grow by 0.21% on average over the next years.
EPS Next Y-155.56%
EPS Next 2Y39.16%
EPS Next 3Y60.49%
EPS Next 5YN/A
Revenue Next Year-1.73%
Revenue Next 2Y0.6%
Revenue Next 3Y0.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
STRF Yearly Revenue VS EstimatesSTRF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
STRF Yearly EPS VS EstimatesSTRF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10

4

4. Valuation

4.1 Price/Earnings Ratio

STRF is valuated cheaply with a Price/Earnings ratio of 3.26.
STRF's Price/Earnings ratio is rather cheap when compared to the industry. STRF is cheaper than 96.44% of the companies in the same industry.
STRF's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.06.
STRF is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 3.26
Fwd PE N/A
STRF Price Earnings VS Forward Price EarningsSTRF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STRF is valued cheaper than 96.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.9
STRF Per share dataSTRF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as STRF's earnings are expected to grow with 60.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.16%
EPS Next 3Y60.49%

0

5. Dividend

5.1 Amount

No dividends for STRF!.
Industry RankSector Rank
Dividend Yield N/A

STRATEGY INC - MSTR 10 PERP

NASDAQ:STRF (9/5/2025, 8:00:01 PM)

111.35

+0.22 (+0.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners49.35%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap31.67B
Analysts80
Price Target170.56 (53.17%)
Short Float %0.54%
Short Ratio5.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20431.8%
Min EPS beat(2)5928.88%
Max EPS beat(2)34934.6%
EPS beat(4)2
Avg EPS beat(4)8888.46%
Min EPS beat(4)-4213.73%
Max EPS beat(4)34934.6%
EPS beat(8)3
Avg EPS beat(8)4019.14%
EPS beat(12)5
Avg EPS beat(12)-6119.95%
EPS beat(16)7
Avg EPS beat(16)-4695.93%
Revenue beat(2)0
Avg Revenue beat(2)-3.32%
Min Revenue beat(2)-6%
Max Revenue beat(2)-0.64%
Revenue beat(4)0
Avg Revenue beat(4)-4.46%
Min Revenue beat(4)-7.22%
Max Revenue beat(4)-0.64%
Revenue beat(8)1
Avg Revenue beat(8)-5.46%
Revenue beat(12)2
Avg Revenue beat(12)-4.4%
Revenue beat(16)2
Avg Revenue beat(16)-4.15%
PT rev (1m)7.92%
PT rev (3m)53.18%
EPS NQ rev (1m)13.94%
EPS NQ rev (3m)20%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-3655.28%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE 3.26
Fwd PE N/A
P/S 68.5
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB N/A
EV/EBITDA 4.9
EPS(TTM)34.12
EY30.64%
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-120.14
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.63
BVpS177.09
TBVpS-49.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.31%
ROE 9.4%
ROCE 12.53%
ROIC 9.9%
ROICexc 9.91%
ROICexgc 13891.1%
OM 1747.64%
PM (TTM) 1023.69%
GM 70.1%
FCFM N/A
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.01
Cap/Depr 85616%
Cap/Sales 7370.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 2.09
F-Score4
WACC10.5%
ROIC/WACC0.94
Cap/Depr(3y)33259.4%
Cap/Depr(5y)26278.5%
Cap/Sales(3y)1735.12%
Cap/Sales(5y)1190.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2065.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5779.44%
EPS Next Y-155.56%
EPS Next 2Y39.16%
EPS Next 3Y60.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%2.73%
Revenue Next Year-1.73%
Revenue Next 2Y0.6%
Revenue Next 3Y0.21%
Revenue Next 5YN/A
EBIT growth 1Y29493.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.67%
EBIT Next 3Y81.44%
EBIT Next 5YN/A
FCF growth 1Y-5676.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13048.8%
OCF growth 3YN/A
OCF growth 5YN/A